Clinical Trials

9 enrolled 9 charts

Brain Neoplasms

NCT02146222 2019-11-18

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

14 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02139150 2019-09-17

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Phase NA Withdrawn

Histologically-confirmed Malignancies

NCT01065805 2019-08-22

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Phase 1/2 Terminated

94 enrolled

CNSLymphoid

Brain Neoplasms, Lymphoma, Neoplasms

NCT02891616 2019-07-17

18F-FLT PET Imaging in Patients With Advanced Melanoma

Phase 1 Terminated

4 enrolled

Dermatologic

Melanoma

NCT01480050 2019-05-22

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

28 enrolled

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT01717391 2019-03-26

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers

GastrointestinalGenitourinaryGynecologic

36 enrolled 5 charts

Anus Neoplasms, Uterine Cervical Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT00276770 2019-02-27

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

12 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00575393 2018-10-09

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

17 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00894101 2018-07-20

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Phase 2/3 Withdrawn

Head and Neck Neoplasms

NCT01610544 2018-07-05

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Hyperplasia, Thymoma, Thymus Neoplasms

NCT01928186 2018-05-15

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

28 enrolled 16 charts

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01825902 2017-11-20

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

1 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Phase EARLY_PHASE1 Completed

30 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00499135 2017-10-10

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

25 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00062374 2017-07-06

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

55 enrolled 7 charts

Gastrointestinal

Stomach Neoplasms

NCT01222416 2017-07-02

PET/CT Evaluation of Treatment Response in Breast Cancer

Phase NA Terminated

50 enrolled 6 charts

Breast Neoplasms

NCT00453362 2017-03-31

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

Phase 1/2 Completed

88 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00963807 2017-03-17

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

26 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00572728 2016-12-30

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

90 enrolled 17 charts

Breast Neoplasms

NCT01283178 2016-10-31

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Phase 1 Terminated

3 enrolled

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms

NCT01480583 2016-07-13

GRABM-B

85 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02241668 2016-02-26

Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma

Phase NA Withdrawn

Brain Neoplasms

NCT01018251 2015-12-15

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Phase NA Withdrawn

Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

NCT00159978 2015-05-07

Validation of 18F-MISO-PET and 18F-FLT-PET

Terminated

21 enrolled

Hypoxia, Head and Neck Neoplasms

NCT00559897 2015-02-04

Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

6 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00534274 2014-12-16

Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy

97 enrolled

Breast Neoplasms

NCT01243359 2014-04-02

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Other hematologic neoplasm

6 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00070239 2013-12-16

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Phase 1 Terminated

100 enrolled

Hematologic Neoplasms

NCT00847509 2013-09-27

FLT101

49 enrolled 4 charts

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT01713049 2012-10-24

18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound

Phase NA Unknown

70 enrolled

Breast Neoplasms

NCT00553748 2008-07-03

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

11 enrolled